ARCHIVES

FDA Expands Gleevec Indication For Children with Ph+ ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998

Abstracts Of Papers From ASCO Meeting

April 7, 1978

GM Downsizes “Nobel Prize” For Cancer; Bristol Ends Medical Research Grants and Awards Program.

June 23, 2006

‘Be Careful We’re Not Fighting Old Battles’ On Study Section Issue

September 20, 1991

Lombardi Recruits Adams-Campbell.

October 3, 2008

Institute of Medicine Elects 80 New Members

October 24, 2014